March 17 (Reuters) - Gilead Sciences Inc GILD.O
* International clinical trials, including trials in Canada,
are being stopped due to serious adverse events with the drug
zydelig, in combination with other cancer drugs
* Is also conducting a review of drug zydelig and will take
appropriate next steps as needed
* Says three additional trials will be amended by
implementing added measures to protect participants
* Four Canadian clinical trials, involving cancer medicine
zydelig (idelalisib) in combination with other cancer medicines,
being stopped
Source text for Eikon: ID:nCNWzmPVDa
Further company coverage: GILD.O
(Bengaluru Newsroom: +1 646 223 8780)